Clinical Trials Sponsored by Pharmaceutical Research Network

Total 2602 results

Pharmaceutical Research Network

Completed

Lumigan Versus Cosopt

Open-Angle Glaucoma

United States
Pharmaceutical Research Network

Completed

Cosopt Versus Xalatan

Ocular Hypertension | Open-Angle Glaucoma

United States
Pharmaceutical Research Network

Completed

Cosopt Versus Xalacom

Ocular Hypertension | Open-Angle Glaucoma

Canada, Slovenia
Pharmaceutical Research Network

Completed

Assessing Cosopt Switch Patients

Ocular Hypertension | Open-Angle Glaucoma | Exfoliation Syndrome | Glaucoma, Pigmentary

United States
Pharmaceutical Research Network

Completed

Latanoprost Versus Fotil

Ocular Hypertension | Open-Angle Glaucoma

Poland
Pharmaceutical Research Network

Completed

Soothe Versus Refresh

Dry Eye Syndromes

United States
Hoosier Cancer Research Network
Novartis Pharmaceuticals

Withdrawn

Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma

Urothelial Carcinoma
GU Research Network, LLC
Churchill Pharmaceutical LLC

Completed

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Prostate Cancer

United States
Aptium Oncology Research Network
Millennium Pharmaceuticals, Inc.

Unknown

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Non-small Cell Lung Cancer

United States
Hoosier Cancer Research Network
Pfizer; Novartis Pharmaceuticals

Completed

Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer

Colorectal Cancer

United States
Accelerated Community Oncology Research Network
Aventis Pharmaceuticals

Completed

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

Breast Neoplasm

United States
Accelerated Community Oncology Research Network
Novartis Pharmaceuticals

Withdrawn

Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer

Cervical Cancer
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Renal Impairment
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)

Chronic HBV Infection

United States, Canada
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-938 in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

Presumptive NAFLD

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

RSV Infection

United States
Alexza Pharmaceuticals, Inc.
Pharmaceutical Research Associates

Unknown

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Agitation,Psychomotor

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

RSV Infection

United States
Oana Danciu
Novartis Pharmaceuticals

Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR)

HER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast Cancer

United States
Matthew Galsky
Novartis Pharmaceuticals; Hoosier Cancer Research Network

Terminated

First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma

Transitional Cell Carcinoma | Urothelial Carcinoma | Bladder Carcinoma

United States
Santhera Pharmaceuticals
European Vision Institute Clinical Research Network

Completed

Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey

Leber Hereditary Optic Neuropathy (LHON)

Belgium, France, Denmark, Italy, Slovenia
Accelerated Community Oncology Research Network
Millennium Pharmaceuticals, Inc.

Terminated

Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma

Multiple Myeloma

United States
Caps Research Network

Terminated

Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief

Migraine

United States
Caps Research Network

Completed

Correlation Between Central Sensitization Inventory and Posturographic Data

Central Nervous System Sensitization

United States, Australia
Continuity Research Network

Completed

Evaluation of a Bright Futures Oral Health Intervention (BFOH)

Health Knowledge, Attitudes, Practice

United States
Wisconsin Research Network

Completed

ASTHMA (AntibioticS To Help Manage Asthma) Pilot Study

Asthma
Caps Research Network

Completed

Posturography Changes During Pregnancy

Pregnant Women

United States
Unither Pharmaceuticals, France
International Pharmaceutical Research Center

Completed

Bioequivalence of IMP 08P1902F0 Relative to Contramal® (100 mg/mL Oral Solution)

Healthy

Jordan
Amneal Pharmaceuticals, LLC
Novum Pharmaceutical Research Services

Completed

Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Noah Hahn, M.D.
Novartis Pharmaceuticals; Hoosier Cancer Research Network

Terminated

Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression

Bladder Cancer

United States
Piedmont Pharmaceuticals, LLC
Lice Solutions Resource Network (LSRN) Research

Completed

A Clinical Trial Evaluating the Efficacy of Resultz Lice and Egg Elimination Kit on Pediatric and Adult Subjects

Pediculus Capitis

United States
Hoosier Cancer Research Network
Genentech, Inc.; Millennium Pharmaceuticals, Inc.

Terminated

Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin

United States
Luke Nordquist, MD
Clarity Pharmaceuticals

Not yet recruiting

64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer

Prostate Cancer

United States
Hoosier Cancer Research Network
Novartis Pharmaceuticals; Walther Cancer Institute

Terminated

PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer

Breast Cancer

United States
Hoosier Cancer Research Network
Novartis Pharmaceuticals; Walther Cancer Institute

Terminated

Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma

Multiple Myeloma

United States
Anchen Pharmaceuticals, Inc
Novum Pharmaceutical Research Services

Completed

Evaluation of Clinical Equivalence Between Two Lubiprostone Products

Chronic Idiopathic Constipation

United States
Anchen Pharmaceuticals, Inc
Novum Pharmaceutical Research Services

Completed

Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

Osteo Arthritis of the Knee

United States
KAI Pharmaceuticals
Nucleus Network Ltd

Completed

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers

Hyperparathyroidism, Secondary

Australia
European Myeloma Network
Janssen Pharmaceutica

Active, not recruiting

A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

Light Chain (AL) Amyloidosis, Stage 3B

Netherlands, Greece, France, Italy
European Myeloma Network
Janssen Pharmaceutica

Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation (MajesTEC-4)

Multiple Myeloma

United Kingdom, Czechia, Australia, Austria, Belgium, Denmark, Germany, Greece, Italy, Netherlands, Norway, Serbia, Switzerland, Turkey, Brazil
Mirum Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc.; Childhood Liver Disease Research and Education...

Completed

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome (IMAGINE-II)

Alagille Syndrome

United States, Canada
Mirum Pharmaceuticals, Inc.
Childhood Liver Disease Research and Education Network

Completed

Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome (ITCH)

Alagille Syndrome

United States, Canada
Accelerated Community Oncology Research Network
Takeda Pharmaceuticals North America, Inc.

Terminated

Treating Chronic Insomnia in Breast Cancer Patients

Chronic Insomnia

United States
Gabi Chiorean, MD
Sanofi; OSI Pharmaceuticals

Terminated

Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas

Hepatocellular Carcinoma

United States
Urological Research Network, LLC

Recruiting

Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach (RCAPN)

Kidney Neoplasms

United States
Urological Research Network, LLC

Recruiting

MRI/Ultrasound Fusion Guided Prostate Cryotherapy (FIPC)

Cancer of the Prostate | Neoplasms Prostate

United States

Clinical Trials Sponsored by Pharmaceutical Research Network

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations